User:Mr. Ibrahem/Phenoxybenzamine
Clinical data | |
---|---|
Trade names | Dibenzyline |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682059 |
Pregnancy category |
|
Routes of administration | By mouth |
Drug class | Alpha blocker[1] |
Pharmacokinetic data | |
Elimination half-life | 24 hours |
Identifiers | |
| |
Chemical and physical data | |
Formula | C18H22ClNO |
Molar mass | 303.83 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Phenoxybenzamine, sold under the brand name Dibenzyline among others, is a medication used to manage pheochromocytoma, peripheral vascular disease, and urinary retention.[1] It is taken by mouth.[1] Effects begin in hours and can last for a week.[1]
Common side effects include a stuffy nose, small pupils, and low blood pressure with standing.[1] Other side effects may include heart problems as a result of a faster heart rate.[1] It should not be used in people with porphyrias.[2] It is an alpha blocker.[1]
Phenoxybenzamine was approved for medical use in the United States in 1953.[1] It is available as a generic medication.[3] In the United States 60 tablets of 10 mg costs about 1,800 USD as of 2021.[3] In the United Kingdom this amount costs the NHS about £240.[2]
References[edit]
- ^ a b c d e f g h i j "Phenoxybenzamine Monograph for Professionals". Drugs.com. Archived from the original on 13 August 2021. Retrieved 28 October 2021.
- ^ a b BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 195. ISBN 978-0857114105.
- ^ a b "Phenoxybenzamine Prices, Coupons & Savings Tips - GoodRx". GoodRx. Archived from the original on 31 October 2016. Retrieved 28 October 2021.